E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/17/2006 in the Prospect News Biotech Daily.

New Issue: Pfizer ¥60 billion five-year bond yields 1.2007%; ¥55 billion 10 year yields 1.808%

By Ronda Fears

Memphis, Feb. 17 - Pfizer, Inc. sold an upsized ¥115 billion of bonds in two parts with a ¥60 billion tranche of five-year 1.2% notes priced at 99.94 to yield 1.2007% and a ¥55 billion tranche of 10-year 1.8% notes priced at 99.56 to yield 1.808%, according to a market source. The deal was boosted from ¥50 billion.

In a Securities and Exchange Commission filing, Pfizer said proceeds from the bond sale would be used for general corporate purposes.

A week ago, Pfizer forecast flat sales in 2006 amid increased competition from generic medicines. The pharmaceutical giant also is exploring various options such as the sale of its over-the-counter pharmaceuticals unit, which is estimated to be worth nearly $4 billion.

Issuer:Pfizer, Inc.
Issue:Global bonds
Amount:¥115 billion, upped from ¥50 billion
Pricing date:Feb. 16
Settlement date:Feb. 22
Tranche A
Amount:¥55 billion
Bookrunners:Mitsubishi UFJ Securities International plc and Goldman Sachs International
Maturity:Feb. 22, 2016
Coupon:1.8%
Price:99.56
Yield:1.808%
Spread:30 bps over comparable Japanese government bond
Price talk:32 bps over comparable Japanese government bond
Ratings:Moody's: Aaa
Standard & Poor's: AAA
Tranche B
Amount:¥60 billion
Bookrunners:Mitsubishi UFJ Securities International plc and Nikko Citigroup
Maturity:Feb. 22, 2011
Coupon:1.2%
Price:99.94
Yield:1.2007%
Spread:22 bps over comparable Japanese government bond
Price talk:22 bps over comparable Japanese government bond
Ratings:Moody's: Aaa
Standard & Poor's: AAA

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.